Marc Beer Is On A Mission To Provide Women With Better Health
Marc Beer has been in the healthcare industry for more than two decades, specifically focused on pharmaceutical and biotechnology. Throughout his career, he has been in many executive positions and has developed his own treatments as well. Today, Marx is the co-founder and Chief Executive Officer at Renovia Inc. Renovia was first founded back in 2016 by Marc Beer, Ramon Iglesias, and Yolanda Lorie. Before founding Renovia, Marc Beer was working at ViaCell, a company he founded and also lead as CEO with more than 300 employees working under him. The main focus of this organization was the development and preservation of stem cells that are found inside the umbilical cord after babies are born.
In the latest series of funding done by Marc Beer, he was able to pull in a deal worth 32 million dollars, which included an extra 10 million dollars through added venture debt. Renovia is only a new Medtech company located in the Boston area, but it quickly building momentum and making a name for itself through the leadership skills of Marc Beer. The primary treatments Renovia is looking at for the time being have to do with pelvic floor disorders in women and they are constantly researching new methods of treatment, including therapeutics. According to estimates, there are hundreds of millions of women around the globe suffering from pelvic floor disorders, which means Renovia could have a far reach and impact around the world if they are successful.
Recently, Renovia was able to put out its very first product that has been approved by the FDA which is being called Leva. Thanks to the successful and generous funding from other organizations, Renovia has a good outlook for the future. Longwood Fund has been one of the leading supporters of the funding rounds at Renovia, with much of the rest coming from link-minded individuals who are looking to create a healthy world for everyone to live in. With more funding, Marc is certain that Renovia could develop more advanced equipment that would be more cost effective for patients with more treatment options, such as a portable Leva device. Learn more : https://renoviainc.com/leadership/